Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Business Exposures
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
VTRS ALERT: Kaplan Fox &amp; Kilsheimer LLP is Investigating Viatris Inc. (VTRS) for Potential Securities Law Violations
Via TheNewswire.com
Tickers VTRS
Exposures Product Safety
FDA Approves Sanofi's Hemophilia Drug
Via Benzinga
Tickers ALNY SNY
Exposures Product Safety
Pretty Healthy Family Launches The PHF Lean Method, a Strength-Based Wellness Program for Women Over 30
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
RFK Jr. Spreading 'Misinformation and Lies'? FDA's Top Vaccine Official Walks Out, Sparking Debate on Safety and Public Trust
Via Benzinga
Exposures Product Safety
VIATRIS Investors Are Encouraged to Contact Kaplan Fox &amp; Kilsheimer LLP Regarding Potential Securities Law Violations
Via TheNewswire.com
Tickers VTRS
Exposures Product Safety
VIATRIS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
Via NewMediaWire
Tickers VTRS
Exposures Product Safety
Alkaline Water Ionizer Distributor VeryHealthyWater Trademark Registration Final
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
International Process Solutions Expands to Offer One-Stop Shop for Calibration, Validation, and Documentation Services
Via AB Newswire
Exposures Product Safety
FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Pool
Via Benzinga
Tickers NVS
Exposures Product Safety
VIATRIS Is Being Investigated for Potential Securities Law Violations Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Tickers VTRS
Exposures Product Safety
VIATRIS Is Being Investigated for Potential Securities Law Violations Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Tickers VTRS
Exposures Product Safety
Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s Positive
Via Stocktwits
Tickers GWX MIST NVDA
Exposures Product Safety
Why DBV Technologies (DBVT) Stock Is Skyrocketing
Via Benzinga
Tickers DBVT
Exposures Product Safety
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish
Via Stocktwits
Topics Earnings
Tickers HUMA IWM NYT VTI
Exposures Financial Product Safety
United Health Products Provides Update on FDA and OTC Markets Applications
Via NewMediaWire
Tickers UEEC
Exposures Product Safety
United Health Products Provides Update on FDA and OTC Markets Applications
Via TheNewswire.com
Tickers UEEC
Exposures Product Safety
European Commission Declines To Renew Marketing Authorization Of Translarna Duchenne Muscular Disorder
Via Benzinga
Tickers PTCT
Exposures Product Safety
Why Is Milestone Pharmaceuticals Stock Plunging Today?
Via Benzinga
Tickers MIST
Exposures Product Safety
Palatin Technologies Touts Positive Results From Mid-Stage Study For Experimental Drug For Ulcerative Colitis, Halts Patients Enrollment Citing Strategic Focus
Via Benzinga
Tickers PTN
Exposures Product Safety
Semaglutide Weight Loss Dosage Chart
Via Syndication Cloud
Exposures Product Safety
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
Via The Motley Fool
Topics Earnings
Tickers HIMS NVO
Exposures Financial Product Safety
James Hardie Upgraded By BofA On AZEK Deal: Analyst Sees Buying Window After Recent Selloff, But Retail Stays Extremely Bearish
Via Stocktwits
Topics Product Recall
Tickers AZEK BAC JHX
Exposures Legal Product Safety
FDA Clears New Mechanical Thrombectomy System
Via 24-7 Press Release
Exposures Product Safety
Palatin Technologies’ Obesity Drug Receives FDA Orphan Designation; Phase 2 Results Imminent (NYSE: PTN)
Via AB Newswire
Tickers PTN
Exposures Product Safety
Soleno Shares Are Up Today: What's Going On?
Via Benzinga
Tickers SLNO
Exposures Product Safety
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Viatris Inc. (VTRS)
Via NewMediaWire
Tickers VTRS
Exposures Product Safety
Kaplan Fox &amp; Kilsheimer LLP is Investigating Potential Securities Law Violations Against Viatris Inc. (VTRS)
Via TheNewswire.com
Tickers VTRS
Exposures Product Safety
Penny Stock Equillium Falls After Itolizumab Treatment Fails To Show Improvement In Response Rates In Graft Versus Host Disease Patients
Via Benzinga
Tickers EQ
Exposures Product Safety
Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?
Via Investor's Business Daily
Tickers GILD MRK REGN VRTX
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at AAPM 2025 PainConnect Meeting
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.